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Objective: This study was undertaken to determine the relationship between plasma
tumor necrosis factor concentrations and hemodynamic and metabolic parameters
during the postoperative clinical course in children undergoing cardiac surgery.
Methods: Tumor necrosis factor levels of 10 consecutive children undergoing
surgery for repair of congenital heart defects were analyzed in blood samples drawn
at predetermined time points during surgery and up to 24 hours thereafter. Clinical
data were collected at these times for correlation to tumor necrosis factor levels.
Results: All the patients survived. Tumor necrosis factor was detected in all 10
children. Tumor necrosis factor levels declined after induction of general anesthesia
(201  65 pg/mL) steadily decreasing during surgery, reaching 80  50 pg/mL at
24 hours after the operation. Tumor necrosis factor levels were found to be inversely
correlated with mean blood pressure values and indicators of acidosis (bicarbonate
levels and base excess, P  .03). They were not correlated with the durations of
cardiopulmonary bypass and aortic crossclamping.
Conclusions: Tumor necrosis factor released into the circulation during and after
pediatric cardiac surgery under cardiopulmonary bypass may be related to the
hemodynamic and acid-base changes observed after cardiac surgery. Elucidation of
the relationship between tumor necrosis factor and patient outcome in high-risk
patients awaits further studies.
Cardiopulmonary bypass (CPB) may initiate a systemic inflamma-tory response, which sometimes leads to significant postoperativehemodynamic deterioration. Tumor necrosis factor (TNF) is amajor proinflammatory cytokine known to be produced in exces-sive amounts after CPB. There are also immunologic sequelae tothis abundance, which may lead to organ injury and postoperative
morbidity. TNF is one of the earliest and most important of the endogenous
mediators released as a result of the inflammatory response. Its essential role in the
inflammatory response,1 the activation of coagulation and complement,2-4 and the
development of septic shock syndrome and multiple organ failure5,6 are widely
recognized.
Previous reports on the plasma TNF response to CPB have yielded conflicting
results. Whereas some authors have demonstrated a significant increase of TNF
concentrations7-9 and stated that TNF is a cardinal mediator in the pathogenesis of
the systemic inflammation, sepsis, and multiple organ failure often seen after cardiac
surgery, others have failed to find any significant changes in TNF levels whatso-
ever,10-12 and some have even reported a decrease in these levels.13,14 Thus despite
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the extensive studies that had been carried out on TNF, its
possible association with morbidity and mortality in the
postoperative course after CPB in infants and children is
still being disputed.
We evaluated a cohort of children undergoing cardiac
surgery under CPB and plotted the time course of plasma
TNF concentrations during and after surgery. We also tried
to correlate plasma TNF levels with the clinical status of the
subjects.
Methods
Patients and Methods
This prospective cohort study included 5 boys and 5 girls (age
range 9 months to 13.5 years) with congenital heart defects for
which they underwent elective cardiac surgery under hypothermic
CPB at the Chaim Sheba Medical Center. We did not include
children with known preexisting causes of vascular injury, such as
recent cardiac arrest, sepsis, or recent severe hypotension. Preop-
erative informed consent was obtained from the parents, and the
institutional ethics committee approved this study.
Selected Patient Data
Demographic data, medical history, and medical variables were
recorded before the operation. Intraoperative parameters and com-
plications included type of cardiac malformation, perfusion man-
agement, and the anesthetics that each child received. Postopera-
tive data were collected at time points corresponding to TNF
sampling and included hemodynamic measures, ventilator status,
and blood gas variables.
Anesthetic Technique
Induction and maintenance of anesthesia were carried out in a
standard manner and consisted of weight-related dosages of fen-
tanyl, midazolam, and pancuronium bromide. All patients were
ventilated to normocapnia with 50% oxygen in air.
Extracorporeal Circulation
The extracorporeal circuit (Baxter Healthcare Corporation Cardio-
Vascular Group, Irvine, Calif) was uncoated and included a Bent-
ley membrane oxygenator, a roller pump (COBE Laboratories,
Gloucester, England) and an arterial filter primed with Ringer’s
lactate solution, blood, and heparin. Conventional CPB techniques
were used. Five minutes before CPB, 300 IU/kg bovine heparin
was administered to achieve anticoagulation. The activated clot-
ting time was monitored and maintained between 400 and 500
seconds with a Hemochron system (Hemochron; International
Techydyne Corp, Edison, NJ).
Surface cooling was obtained by maintaining low room tem-
perature and by a cooling mattress in addition to ice packs placed
near the child’s head. Cooling was achieved by cold (4°C) crys-
talloid antegrade cardioplegia, which was infused through the
aortic root. The core temperature was reduced to 27°C  4.5°C.
At the end of the procedure, the crossclamp was removed and
the patient was rewarmed while remaining under conditions of
CPB. No modified ultrafiltration or leukocyte depletion techniques
were used for any of the children in this study. The heparin that
was administered during surgery was neutralized with protamine
sulfate at a ratio of 1:1.
Blood Samples
Thirteen serial arterial blood samples were collected from each
child from the arterial line or the extracorporeal circuit. The
sample taken after the induction of anesthesia was considered as
the baseline value; the other 12 time points were after connection
to CPB, 1 hour after CPB, at aortic clamping and declamping, at
CPB cessation, at the end of the operation (skin closure), and at 1,
2, 4, 8, 12, and 24 hours after the operation, while the child was in
the intensive care unit. Plasma was recovered immediately from
these samples by centrifugation at 3000g for 10 minutes at 4°C,
divided into aliquots, and frozen at 70°C until use.
TNF Assay
TNF was detected with a Bio-source Cytoscreen kit (BioSource
International, Inc, Camarillo, Calif). This is a highly sensitive
enzyme-linked immunosorbent assay that measures both free and
receptor bound TNF, and is capable of detecting TNF levels of less
than 1 pg/mL. All the results from the enzyme-linked immunosor-
bent assay measurements represent the means from duplicate mea-
surements.
Statistical Analysis
All parameters are expressed as mean  SD. TNF levels and
clinical data were evaluated with analysis of variance and covari-
ance with repeated measures. The correlation between TNF levels
and the clinical variables was investigated by regression and
correlation tests.
Results
The types of cardiac malformation and the surgical and
perioperative data of the 10 study children are presented in
Tables 1 and 2. All the patients survived surgery. TNF was
detected in each. The plasma TNF concentrations across
time are shown in Figure 1. The TNF levels decreased
immediately after CPB connection and continued to de-
crease during surgery and in the intensive care unit (P 
.0001). The TNF levels were 201.4  134 pg/mL at induc-
tion and decreased to 145.5  62.8 pg/mL after the begin-
ning of CPB (P  .03). They continued to decrease until
they reached a trough—although they were still at higher
than normal levels—at the end of surgery (80.2  57.3
pg/mL) and stayed at these abnormal levels for 24 hours
thereafter.
We found an inverse correlation between TNF concen-
TABLE 1. Cardiac malformations (n  10)
Type No.
Tetralogy of Fallot 3
Atrial septal defect 3
Ventricular septal defect 2
Atrioventricular canal 1
Mitral stenosis 1
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trations and mean blood pressure (P  .003; Figure 2). The
pH values decreased as soon as the child was connected to
CPB and reached their lowest level at 1 hour after CPB was
initiated (Figure 3). The TNF levels were also inversely
correlated with two acidosis indicators, bicarbonate levels
and base excess (P  .03; Figures 4 and 5).
Discussion
This prospective cohort study involved children undergoing
cardiac surgery under CPB for the repair of congenital heart
defects. To the best of our knowledge, this is the first study
to show that TNF is correlated with indicators of metabolic
acidosis, well-known markers of tissue perfusion, and indi-
cators of cellular hypoxia. Furthermore, plasma TNF levels
were demonstrated to be inversely correlated with mean
blood pressure.
The TNF response to CPB has been widely investigated,
because both of result in the same complications: inflam-
mation, infection, edema, leukocytosis, fever, and multiple
organ dysfunction syndrome (MODS).5,7,15 The contact of
blood with the extracorporeal circuit activates various cas-
cades, including the synthesis of inflammatory media-
tors.8,15,16 The data on TNF response to CPB are inconsis-
tent. Whereas some authors have observed an increase in
TNF concentrations in these patients,7,8,17 others have found
either no significant change whatsoever10-12 or even a de-
crease in TNF levels.13,14
We found that high levels of TNF in our study children
were inversely correlated with the levels of bicarbonate and
base excess. These findings are in accordance with previous
reports showing that serum lactate may be an accurate
predictor of the postoperative course.18 Despite the fact that
serum pH and bicarbonate do not always correlate with
intracellular pH, and it is the latter that is of primary
importance, only extracellular plasma pH and lactate can be
easily measured in patients to provide an accurate assess-
ment of acid-base status. Elevated lactate levels represent
inadequate oxygen delivery as a result of hypoperfusion and
hypoxemia. Lactic acidosis during surgery was found to be
an early and specific indicator of patients at high risk for
morbidity and mortality after operations for congenital car-
diac disease.18 High lactate levels were found to predict
MODS, the requirement of extracorporeal membrane oxy-
genator support, circulatory arrest, and death.19,20 It can be
assumed that the endothelial reaction to the institution of the
extracorporeal circulation, causing the release of TNF, is
also reflected by the degree of vasoconstriction, hypoperfu-
sion, and the evolving metabolic acidosis, as reflected by
low bicarbonate and pH values.
We also found that TNF levels were inversely correlated
with mean blood pressure, in agreement with the findings of
Jansen and colleagues.21 Attempts to correlate cytokine
levels with the clinical course of the patients after CPB have
also been made before by others. Casey and coworkers7
described a higher heart rate and a lower central venous
pressure in patients with high TNF levels, and our results
appear to confirm their findings. Steinberg and colleagues10
could not find a significant correlation among hemodynamic
variables or pulmonary function and TNF after CPB. Ou-
demans-van Straaten and associates22 reported that in-
creased oxygen consumption after CPB was associated with
the inflammatory response and TNF secretion. Similarly,
Khabar and coworkers23 found an association between in-
creased TNF and systemic inflammatory response followed
by MODS in the postoperative period after cardiac surgery.
Pilz and associates24 suggested that TNF levels and TNF
receptors could predict postsurgical clinical outcome and
mortality in adults. The levels of TNF and its soluble
receptors, p55 and p75, were higher in patients with presur-
gical criteria for high risk of development of postsurgical
sepsis than in the control group. The former group showed
more clinical complications and a higher mortality rate, and
Pilz and associates24 therefore concluded that these media-
tors hold prognostic value.
Similar to our results, other studies showed a decrease in
TNF concentrations with time after the institution of CPB in
adults.13,14 Kawamura and associates14 investigated 11 adult
patients who underwent surgery with CPB and reported that
serum TNF levels did not increase during the operation
relative to preoperative levels; in fact, TNF levels decreased
at 60 minutes after aortic occlusion. Markewitz and col-
leagues13 reported a decrease in TNF levels on the first day
after surgery relative to preoperative levels and that they
remained depressed for 7 days; the administration of indo-
methacin resulted in a substantial increases in TNF synthe-
sis. Steinberg and colleagues10 demonstrated significant in-
creases in complement and interleukins but failed to find
any evidence of TNF. Butler and coworkers11 detected TNF
in only half their adult subjects and observed no variations
in its levels. They reasoned that their findings were due to
the short half-life of TNF and the consequent likelihood that
it might be missed or released locally in specific organs,
such as the lung. Several additional similar studies in chil-
dren and adults have reported either no increase in TNF25,26
or no evidence of it at all.27-29
TABLE 2. Study patients’ surgical and perioperative data
(n  10, 5 male and 5 female patients)
Variable Mean  SD Range
Age (y) 4.36 4.49 0.75-13.5
Weight (kg) 17.27 14.28 6-52
Surgery duration (h) 4.08 0.77 3-5.3
CPB duration (h) 1.33 0.83 0.2-2.4
Aortic clamp duration (h) 0.82 0.60 0.3-1.8
Stay in intensive care unit (d) 6.0 2.6 2-9
Mechanical ventilation (d) 2.50 1.51 1-6
Minimal temperature (°C) 27 4.50 25-34
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Whereas data on TNF in the adult population are well
known, the pediatric population has been far less studied.
Importantly, cytokine production has been shown to differ
in various age groups.20,30 Casey and coworkers7 reported
an increase of endotoxin and TNF in 88% of children during
heart surgery, but they could not relate TNF levels to
intraoperative clinical data or postoperative morbidity. Hat-
tler and associates31 demonstrated TNF messenger RNA
transcription in all their adult patients during CPB, with the
highest values in the ones in whom the duration of CPB was
longest.
The TNF concentrations that were determined in our
study were high compared with the TNF levels reported in
other similar works, possibly because we used an immuno-
assay that measures free TNF as well as the TNF in TNF-
receptor complexes and therefore would be expected to
show high TNF concentrations. The highest levels of TNF
were identified immediately after induction of anesthesia.
Because all lines were installed after induction of anesthe-
sia, no blood samples were taken earlier. Therefore the
exact relationship between anesthesia and TNF levels could
not be defined. However, the highest TNF levels in our
study were detected at the time point after induction of
anesthesia. This could be explained by the effect of anes-
thetic drugs. Both intravenous anesthetics32 and inhalational
agents33 have been shown to be capable of promoting a
significant cytokine response, resulting in the release of
TNF. When the element of a CPB connection is added there
is dilution of the plasma, and this event lowers the concen-
trations of cytokines.
Whereas this evidence supports a pathogenic role for
TNF in the postoperative course, experimental studies on
inhibition of TNF are beginning to emerge. For example,
hemofiltration during CPB removes excess fluids and filters
out some cytokines.34-36 Moreover, TNF may be inhibited
by steroids,5,18,37 by the use of anti–TNF monoclonal anti-
bodies,38,39 or by other cytokines, such as interleukin 10,
interleukin 4, and granulocyte colony-stimulating fac-
tor.6,40,41 Bonding TNF to specific receptors can prevent
postpump syndrome,41 and synthesis of TNF can be inhib-
ited by amrinone, cyclosporine (INN: ciclosporin), or de-
sensitization.6 Other means of antagonizing TNF activity
after CPB include the administration of aprotinin, a serine
protease inhibitor, or specific receptors that can bind TNF,
thus preventing its activity after being released to the blood-
stream.41-43
TNF was sampled 13 times in each child, most fre-
quently during CPB and in the first postoperative hours, to
Figure 1. Changes in plasma TNF levels with time before, during, and after CPB. End of surgery was defined as skin
closure. First 6 samples were collected at fixed time intervals after CPB cessation. Ao Cl on, Aortic crossclamp
placement; Ao Cl off, aortic crossclamp removal.
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exclude the possibility of missing a transient but significant
TNF surge. The frequent sampling increased the validity of
the results and enabled us to examine the TNF response in
relation to each surgical step. TNF was detected in all the
children. TNF levels were highest after induction and de-
creased gradually during and after the operation. Thus the
Figure 2. Changes in plasma TNF (squares) and mean blood pressure (MBP, circles) with time. End of surgery was
defined as skin closure.
Figure 3. Changes in plasma TNF (squares) and pH (circles) with time. End of surgery was defined as skin closure.
Ao Cl on, Aortic crossclamp placement; Ao Cl off, aortic crossclamp removal.
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results of this study add more lines of evidence to a growing
body of literature describing the robust proinflammatory
response to CPB.
Our data lend additional support to the hypothesis that
TNF is associated with acid-base disturbances after cardiac
surgery. It is unclear whether TNF and acid-base abnormal-
Figure 4. Changes in plasma TNF (squares) and bicarbonate level (HCO3, circles) with time. End of surgery was
defined as skin closure. Ao Cl on, Aortic crossclamp placement; Ao Cl off, aortic crossclamp removal.
Figure 5. Changes in plasma TNF (squares) and base excess (BE, circles) with time. End of surgery was defined
as skin closure. Ao Cl on, Aortic crossclamp placement; Ao Cl off, aortic crossclamp removal.
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ities are causally related phenomena or simply independent
markers of injury after cardiac surgery. Interpretation of our
results is limited by the small number of study children, a
feature shared by most studies such as ours. Furthermore,
ours was a relatively low-risk population, and none of the
patients had any adverse effects during or after CPB. An-
other limitation of the study is that TNF was measured after
induction of anesthesia. Therefore these data can serve as a
baseline to indicate cytokine production in routine cardiac
surgical procedures. Additional investigations on larger
numbers of patients at higher risk and the use of the same
immunoassay kit for all blood samples are essential to
finding potential stimuli for TNF release and to confirming
the relationship that we have described between TNF levels
and the postoperative clinical course in children undergoing
cardiac surgery.
In conclusion, children undergoing cardiac surgery ex-
hibited high TNF levels after anesthetic induction. These
values decreased gradually during and after surgery. TNF
levels were inversely correlated with mean blood pressure,
bicarbonate levels, and base excess. These novel data may
have far-reaching therapeutic implications and thus warrant
further large-scale investigation. Further studies will be
necessary to clarify the association between TNF and the
postoperative course in patients undergoing cardiac surgery.
We thank Esther Eshkol for editorial assistance.
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